Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Onward Therapeutics Signs an Exclusive Collaboration and Worldwide Option and License Agreement with Institut du Cancer de Montpellier 2021-06-08 12:00
Ying Hai Announces Possible Acquisition of a Zhuhai Travel Company 2021-06-08 11:35
Vestas wins 32 MW order in Japan 2021-06-08 11:26
A Snapshot of SID Display Week 2021: BOE leads the way in display industry, bringing momentum to "China's moment" 2021-06-08 11:17
2021 SNEC丨Arctech Signed MoU 1GW Solar Tracker Delivery Worldwide 2021-06-08 11:01
Pearl Abyss Releases BUGATTI Collaboration for Black Desert 2021-06-08 10:47
Provides Delivery Service in Indonesia, Wehelpyou Introduces the Concept of Digital Orchestrator 2021-06-08 10:23
ViewSonic Introduces ToF Technology to its Latest Portable LED Projector M2e to achieve Instant Auto Focus 2021-06-08 10:03
Cytiva opens experience and learning lab in Singapore 2021-06-08 10:00
Carousell Sets Its Sights on a New Era of Growth with CFO Appointment 2021-06-08 10:00
CGTN launches 'Media Challengers' theme song 2021-06-08 09:58
CGTN: Peng Liyuan calls for global efforts in AIDS and TB prevention and treatment 2021-06-08 09:37
Hivestack partners with Vpon to bring Hong Kong and Taiwan marketers data-driven DOOH targeting 2021-06-08 09:00
PingPong Payments launches new PLN and SEK currency exchange services 2021-06-08 09:00
BST Global Presents "The Journey to Project Intelligence" 2021-06-08 08:41
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress 2021-06-08 08:00
Mech-Mind Announces New-Gen Mech-Eye Pro Enhanced Industrial 3D Camera to Enable Smarter Robotics of Industry 4.0 2021-06-08 08:00
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL 2021-06-08 07:30
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs 2021-06-08 07:21
American Sealants, Inc. Expands International Service Offering for the Construction of Water Retaining and Animal Exhibits 2021-06-08 05:24